Mental Disorders: Designing a Clinical Study

Mental disorders are an important thing to study so that people can learn about what causes and aggravates such conditions, and what treatments are best for dealing with everything from depression to schizophrenia. Designing a thorough clinical study ensures that all possible side effects of medications will be clear, and that treatments really work.  The following are some tips on how to design the best possible clinical study.

When designing a clinical study, it helps to know your options. The classic scientific approach to running a clinical study is using the randomized, controlled and double blind method. Doing this will ensure the integrity of the study's results. If you invest in clinical research, it will allow you to compare a new treatment to an old treatment. This way, you can see which is most effective when it comes to battling mental disorders. To do this, you will need to find a large group of subjects to test different treatment methods.

When designing a clinical study for mental disorders, you need to make sure that you have a control group. This group will take the existing or proven treatment method, or they may end up taking a placebo. A placebo is a pill that does not treat the mental illness even if the participants in the study think it does. The medicine they are given could be something as simple and as common as Ibuprofen or could even be a sugar pill. The control group is integral to any clinical study. After all, it gives researchers something with which to compare the new treatment or medication. This group will help researchers to see if the changes in the experimental group are because of the new medication, and not some unknown factor.

Participants in a clinical study are randomly assigned to their groups. This randomization helps to eliminate bias. This random assignment also ensures that the groups are as similar as possible. This makes comparison of the effects of the pills or treatments that much easier. After all, if the make-up of the groups is similar, the researcher can focus more intently on the effects of the treatments and make more accurate conclusions.

To help keep bias at bay during a clinical study, it helps if the researchers do not know which person is in which group. This will help the researchers avoid making premature conclusions when spotting what they might perceive to be shifts in behavior or side effects. This is why the study is called double-blind.

The last step of any clinical study is to have the participants provide their informed consent. This means that you have fully explained the focus of this study and what will be required. Without this form, you may be in trouble with the IRB board. Informed consent is important because it protects both the participants and researchers in a trial or study. Without this form, your study may be deemed unethical and unreliable.

Drawing upon our more than 30-year history of granting degrees in professional psychology, Argosy University has developed a curriculum that focuses on interpersonal skills and practical experience alongside academic learning. Because getting a degree is one thing. Succeeding, quite another.